Renal Denervation Market Analysis, Share, Size and Forecast to 2020
- Submitted by: Marketreport
- Views: 94
- Category: Other
- Date Submitted: 08/17/2016 02:18 AM
- Pages: 3
- Report this Essay
Technavio Announces the Publication of its Research Report Global Renal Denervation Market 2016-2020
Technavio recognizes the following companies as the key players in the global renal denervation market: Boston Scientific, Medtronic, ReCor Medical, and St. Jude Medical.
Other Prominent Vendors in the market are: Cardiosonic, Cordis, Kona Medical, Sound Intervention, and Terumo.
Browse full report with TOC@ https://marketreportscenter.com/reports/349481/global-renal-denervation-market-2016-2020
Commenting on the report, an analyst from Technavios team said: Increase in M&A will be a key trend for market growth. Vendors present in the market are undergoing M&A to expand their global presence, mitigate the loss of patent protection, expand their product portfolio, and achieve economies of scale. For instance, Boston Scientific acquired Vessix Vascular, a developer of catheter-based renal denervation systems for treating uncontrolled hypertension, in January 2012. Boston Scientific expects that the Vessix Vascular renal denervation system will help it gain market leadership. These types of M&A will provide substantial synergies for many vendors, including an enviable combination to access a global customer base, as well as complement expansion of product portfolios.
According to the report, widespread prevalence of hypertension will be a key driver for market growth. Unhealthy diet, stress, and physical inactivity can lead to conditions such as hypertension, hypercholesterolemia, coronary artery disease, and diabetes. Hypertension or high blood pressure can cause ischemia and stroke. With each passing year, the prevalence of hypertension is rising worldwide. In 2013, CDC estimated that more than 30% of the global adult population had hypertension.
Further, the report states that alternative treatment options will be a major challenge for the market. Renal denervation devices are technologically advanced, are safe to use, and offer a one-time...
Technavio recognizes the following companies as the key players in the global renal denervation market: Boston Scientific, Medtronic, ReCor Medical, and St. Jude Medical.
Other Prominent Vendors in the market are: Cardiosonic, Cordis, Kona Medical, Sound Intervention, and Terumo.
Browse full report with TOC@ https://marketreportscenter.com/reports/349481/global-renal-denervation-market-2016-2020
Commenting on the report, an analyst from Technavios team said: Increase in M&A will be a key trend for market growth. Vendors present in the market are undergoing M&A to expand their global presence, mitigate the loss of patent protection, expand their product portfolio, and achieve economies of scale. For instance, Boston Scientific acquired Vessix Vascular, a developer of catheter-based renal denervation systems for treating uncontrolled hypertension, in January 2012. Boston Scientific expects that the Vessix Vascular renal denervation system will help it gain market leadership. These types of M&A will provide substantial synergies for many vendors, including an enviable combination to access a global customer base, as well as complement expansion of product portfolios.
According to the report, widespread prevalence of hypertension will be a key driver for market growth. Unhealthy diet, stress, and physical inactivity can lead to conditions such as hypertension, hypercholesterolemia, coronary artery disease, and diabetes. Hypertension or high blood pressure can cause ischemia and stroke. With each passing year, the prevalence of hypertension is rising worldwide. In 2013, CDC estimated that more than 30% of the global adult population had hypertension.
Further, the report states that alternative treatment options will be a major challenge for the market. Renal denervation devices are technologically advanced, are safe to use, and offer a one-time...